Announcements Trials
Browse Landscape

Phase

Phase 2 118Phase 3 64Phase 1/2 26Phase 1 13Phase NA 8Phase 2/3 7Phase 4 4Phase EARLY_PHASE1 1

Status

Completed 13Unknown 4Recruiting 4Terminated 3Not yet recruiting 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Breast 2Head & Neck 1

Conditions

Colorectal Neoplasms 2Recurrence 1Neoplasm Metastasis 1Locally Advanced Colorectal Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Breast Neoplasms 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Capecitabine × Clear all
NCT07158164 2025-11-13

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Rutgers, The State University of New Jersey

Phase 4 Recruiting
100 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

NCT06090994 2025-05-07

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Fudan University

Phase 4 Recruiting
756 enrolled
Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT06550453 2024-11-12

Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

Xijing Hospital

Phase 4 Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Colorectal Cancer

NCT06217185 2024-02-28

The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Hebei Medical University Fourth Hospital

Phase 4 Recruiting
100 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡